• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE CARDIOFORM SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE CARDIOFORM SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL Back to Search Results
Catalog Number GSX0030A
Device Problem Fracture (1260)
Patient Problems Cardiac Tamponade (2226); Cardiac Perforation (2513); Foreign Body In Patient (2687)
Event Date 05/06/2017
Event Type  Injury  
Manufacturer Narrative
The device was not returned for evaluation, and a device lot number was not provided; therefore, an investigation was unable to be performed and a cause of the reported event was unable to be determined.
 
Event Description
It was reported a gore helex septal occluder was implanted in a patient in early 2015.On (b)(6) 2017, the patient was found in cardiac tamponade and admitted through the emergency room to the hospital¿s cath lab.Echocardiographic images demonstrated a large shunt from the aorta to the right side of the heart.Pericardiocentesis was performed and the patient stabilized.Follow-up cardiac angiographic computed tomography imaging was scheduled.On (b)(6) 2017, the patient underwent surgery and the helex device was explanted.It was further reported that the right atrial disc was fractured and had punctured through the right atrial free wall and into the aorta.The patient was stable following surgery.
 
Manufacturer Narrative
Additional information received indicates the device is a gore® cardioform septal occluder, not a gore® helex® septal occluder, as originally reported.The gore® cardioform septal occluder instructions for use note that potential device or procedure-related adverse events may include device fracture resulting in clinical sequelae or surgical intervention.Also, additional information received notes the device was used to close a patent foramen ovale.The gore® cardioform septal occluder indications/intended use state "the gore® cardioform septal occluder is a permanently implanted device indicated for the percutaneous, transcatheter closure of ostium secundum atrial septal defects (asds).".
 
Manufacturer Narrative
Gore® cardioform septal occluder, (b)(4).
 
Manufacturer Narrative
A review of the manufacturing records verified the lot was processed normally and all pre-release specifications were met.
 
Manufacturer Narrative
Article citation: kumar p, orford jl, tobis jm.Two cases of pericardial tamponade due to nitinol wire fracture of a gore septal occluder.Catheter cardiovasc interv.2019;1¿6.Https://doi.Org/10.1002/ccd.28596.Added information: (b)(6), date of birth (b)(6) 1963.Lot #14116730; expiration date 7/26/2017; unique identifier # (b)(4).Corrected information: catalog # gsx0030a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE CARDIOFORM SEPTAL OCCLUDER
Type of Device
OCCLUDER, TRANSCATHETER SEPTAL
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
marci stewart
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6581740
MDR Text Key75652934
Report Number2017233-2017-00269
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 03/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/26/2017
Device Catalogue NumberGSX0030A
Device Lot Number14116730
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/22/2017
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Not provided
Supplement Dates FDA Received09/11/2017
09/21/2017
02/18/2020
03/30/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/27/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age54 YR
-
-